Keystone Symposia

This meeting took place in 2014

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Alzheimer’s Disease – From Fundamental Insights to Light at the End of the Translational Tunnel (Q8)

Organizer(s) John Q. Trojanowski, Charles F. Albright and Hui Zheng
March 2—7, 2014
Keystone Resort • Keystone, CO USA
Discounted Abstract Deadline: Nov 5, 2013
Abstract Deadline: Dec 5, 2013
Scholarship Deadline: Nov 5, 2013
Discounted Registration Deadline: Jan 8, 2014

Sponsored by AstraZeneca, Genentech, Inc., Pfizer Inc., Roche and Takeda Pharmaceutical Company Limited

Summary of Meeting:
Alzheimer’s disease (AD), Parkinson’s disease (PD) and related neurodegenerative disorders are becoming increasingly more prevalent in the United States and globally due to the longevity revolution. The consequences of these diseases are grave, both for individuals and the global community, prompting concerns that rising healthcare costs have the potential to result in deleterious effects on national economies that could spell disaster unless disease-modifying therapies are discovered very soon. Fortunately, remarkable progress has been made toward elucidating mechanisms of AD since the discovery of the Abeta peptide in 1984, which launched the molecular era of AD research. That, coupled with the demonstration that tau is a building block of AD tangles in 1991, led to the understanding that AD, PD and most other neurodegenerative disorders are protein misfolding diseases, which has led to further clarity about mechanisms underlying AD. This has culminated in the identification of new targets for disease-modifying therapies as well as biomarkers for AD. Most recently, provocative data have emerged suggesting that the progression of AD may be due to the cell-to-cell spread of pathological species of tau and Abeta, thereby ushering in exciting new opportunities to arrest AD progression with immune therapies. Thus, the purpose of this meeting, which will be held in concert with a parallel meeting on “Parkinson’s Disease: Genetics, Mechanisms and Therapeutics,” is to explore these fundamental insights into mechanisms of AD and the opportunities they provide to translate this knowledge into meaningful interventions for AD.

View Meeting Program


National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients

Cristian A. Lasagna-Reeves
Baylor College of Medicine, USA

Chandler Walker
Columbia University, USA

National Institute of Neurological Disorders and Stroke (NINDS) Scholarship Recipients

Carmen Inda
Memorial Sloan Kettering Cancer Center, USA

Shannon L. Macauley-Rambach
Washington University School of Medicine, USA

Raj Towfique
Mount Sinai School of Medicine, USA

The Barrie Hesp Scholarship on behalf of Ashley Rebecca Cukier Scholarship Recipients

Eva Czirr
Alkahest, USA

Mitsuru Shinohara
Mayo Clinic, USA